A Chicoye
Impact in
- Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
- Physiology top 10%
- Asthma and respiratory diseases
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 9
- Pharmaceutical Economics and Policy 2
-
- Medication Adherence and Compliance 3
- Co-authors
- Jean Bousquet (2 shared papers)Henriette Dhivert (1 shared paper)Jalel Knani (1 shared paper)John E. Ware (1 shared paper)François Bernard Michel (1 shared paper)Françoise Neukirch (1 shared paper)Pierre Scheinmann (1 shared paper)R. Fadel (1 shared paper)
- Journals
- Value in Health (4 papers)Vaccine (2 papers)L Encéphale (1 paper)Vaccines (1 paper)PLoS ONE (1 paper)
- Partner nations
- FranceUnited KingdomNetherlands
In The Last Decade
A Chicoye
17 papers receiving 482 citations
Peers
Comparison fields: 5 of 51
- Immunology and Allergy 104
- Physiology 186
- Family Practice 14
- Economics and Econometrics 102
- Pharmacology 21
Countries citing papers authored by A Chicoye
This map shows the geographic impact of A Chicoye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Chicoye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Chicoye more than expected).
Fields of papers citing papers by A Chicoye
This network shows the impact of papers produced by A Chicoye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Chicoye. The network helps show where A Chicoye may publish in the future.
Co-authors
The 25 scholars most cited alongside A Chicoye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 332 | |
| 2 | Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France. | 2007 | 46 |
| 3 | 2005 | 39 | |
| 4 | 2019 | 26 | |
| 5 | 2022 | 24 | |
| 6 | 2016 | 23 | |
| 7 | 2007 | 11 | |
| 8 | 2023 | 5 | |
| 9 | 2024 | 4 | |
| 10 | 2025 | 4 | |
| 11 | 2007 | 3 | |
| 12 | 2001 | 2 | |
| 13 | 2006 | 2 | |
| 14 | 1988 | 1 | |
| 15 | [Functional and occupational repercussions and seeking care services in chronic asthma]. | 1994 | 1 |
| 16 | L'évaluation médico-économique de l'hémophilie à l'aube du troisième millénaire | 2002 | 1 |
| 17 | 2016 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2022 | 1 |
About A Chicoye
A Chicoye is a scholar working on Economics and Econometrics, Family Practice, Pharmacology, Physiology and Immunology and Allergy, having authored 19 papers that have together received 527 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Medication Adherence and Compliance (3 papers), Pharmaceutical Economics and Policy (2 papers), Asthma and respiratory diseases (2 papers), Pharmacy and Medical Practices (2 papers), Streptococcal Infections and Treatments (1 paper), Hemophilia Treatment and Research (1 paper) and Schizophrenia research and treatment (1 paper). The work is most often cited by research in Immunology and Allergy (104 citations), Physiology (186 citations), Family Practice (14 citations), Economics and Econometrics (102 citations) and Pharmacology (21 citations). A Chicoye has collaborated with scholars based in France, United Kingdom and Netherlands. Frequent co-authors include Jean Bousquet, Henriette Dhivert, Jalel Knani, John E. Ware, François Bernard Michel, Françoise Neukirch, Pierre Scheinmann, R. Fadel, Pierre‐Michel Llorca and Isabelle Durand‐Zaleski. Their work appears in journals such as Value in Health, Vaccine, L Encéphale, Vaccines and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.